We've found
161,353
archived clinical trials in
Cancer
We've found
161,353
archived clinical trials in
Cancer
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
Updated: 6/30/2016
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
Updated: 6/30/2016
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
Click here to add this to my saved trials

PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
Updated: 6/30/2016
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
Updated: 6/30/2016
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
Click here to add this to my saved trials

PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
Updated: 6/30/2016
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
Updated: 6/30/2016
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
Click here to add this to my saved trials

PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
Updated: 6/30/2016
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
Updated: 6/30/2016
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
Click here to add this to my saved trials

PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
Updated: 6/30/2016
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
Updated: 6/30/2016
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
Click here to add this to my saved trials

PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
Updated: 6/30/2016
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
Updated: 6/30/2016
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
Click here to add this to my saved trials

PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
Updated: 6/30/2016
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
Updated: 6/30/2016
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
Click here to add this to my saved trials

PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
Updated: 6/30/2016
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
Updated: 6/30/2016
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
Click here to add this to my saved trials

PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
Updated: 6/30/2016
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
Updated: 6/30/2016
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
Click here to add this to my saved trials

PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
Updated: 6/30/2016
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
Updated: 6/30/2016
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
Click here to add this to my saved trials

PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
Updated: 6/30/2016
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
Updated: 6/30/2016
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
Click here to add this to my saved trials

PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
Updated: 6/30/2016
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
Updated: 6/30/2016
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
Click here to add this to my saved trials

PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
Updated: 6/30/2016
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
Updated: 6/30/2016
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
Click here to add this to my saved trials

PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
Updated: 6/30/2016
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
Updated: 6/30/2016
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
Click here to add this to my saved trials

PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
Updated: 6/30/2016
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
Updated: 6/30/2016
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
Click here to add this to my saved trials

PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
Updated: 6/30/2016
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
Updated: 6/30/2016
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
Click here to add this to my saved trials

PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
Updated: 6/30/2016
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
Updated: 6/30/2016
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
Click here to add this to my saved trials

PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
Updated: 6/30/2016
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
Updated: 6/30/2016
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
Click here to add this to my saved trials

PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
Updated: 6/30/2016
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
Updated: 6/30/2016
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
Click here to add this to my saved trials

PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
Updated: 6/30/2016
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
Updated: 6/30/2016
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
Click here to add this to my saved trials

PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
Updated: 6/30/2016
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
Updated: 6/30/2016
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
Click here to add this to my saved trials

PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
Updated: 6/30/2016
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
Updated: 6/30/2016
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
Click here to add this to my saved trials

PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
Updated: 6/30/2016
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
Updated: 6/30/2016
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
Click here to add this to my saved trials

PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
Updated: 6/30/2016
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
Updated: 6/30/2016
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
Click here to add this to my saved trials

PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
Updated: 6/30/2016
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
Updated: 6/30/2016
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
Click here to add this to my saved trials

PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
Updated: 6/30/2016
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
Updated: 6/30/2016
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
Click here to add this to my saved trials

PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
Updated: 6/30/2016
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
Updated: 6/30/2016
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
Click here to add this to my saved trials

PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
Updated: 6/30/2016
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
Updated: 6/30/2016
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
Click here to add this to my saved trials

PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
Updated: 6/30/2016
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
Updated: 6/30/2016
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
Click here to add this to my saved trials

PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
Updated: 6/30/2016
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
Updated: 6/30/2016
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
Click here to add this to my saved trials

PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
Updated: 6/30/2016
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
Updated: 6/30/2016
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
Click here to add this to my saved trials

PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
Updated: 6/30/2016
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
Updated: 6/30/2016
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
Click here to add this to my saved trials

PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
Updated: 6/30/2016
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
Updated: 6/30/2016
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
Click here to add this to my saved trials

PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
Updated: 6/30/2016
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
Updated: 6/30/2016
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
Click here to add this to my saved trials

PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
Updated: 6/30/2016
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
Updated: 6/30/2016
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
Click here to add this to my saved trials

PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
Updated: 6/30/2016
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
Updated: 6/30/2016
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
Click here to add this to my saved trials

PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
Updated: 6/30/2016
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
Updated: 6/30/2016
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
Click here to add this to my saved trials

PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
Updated: 6/30/2016
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
Updated: 6/30/2016
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
Click here to add this to my saved trials

PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
Updated: 6/30/2016
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
Updated: 6/30/2016
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
Click here to add this to my saved trials

PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
Updated: 6/30/2016
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
Updated: 6/30/2016
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
Click here to add this to my saved trials

PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
Updated: 6/30/2016
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
Updated: 6/30/2016
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
Click here to add this to my saved trials

PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
Updated: 6/30/2016
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
Updated: 6/30/2016
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
Click here to add this to my saved trials

PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
Updated: 6/30/2016
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
Updated: 6/30/2016
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
Click here to add this to my saved trials

PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
Updated: 6/30/2016
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
Updated: 6/30/2016
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
Click here to add this to my saved trials

PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
Updated: 6/30/2016
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
Updated: 6/30/2016
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
Click here to add this to my saved trials

PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
Updated: 6/30/2016
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
Updated: 6/30/2016
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
Click here to add this to my saved trials

PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
Updated: 6/30/2016
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
Updated: 6/30/2016
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
Click here to add this to my saved trials

PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
Updated: 6/30/2016
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
Updated: 6/30/2016
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
Click here to add this to my saved trials

PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
Updated: 6/30/2016
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
Updated: 6/30/2016
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
Click here to add this to my saved trials

PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
Updated: 6/30/2016
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
Updated: 6/30/2016
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
Click here to add this to my saved trials
